Anticoagulant therapy for idiopathic pulmonary fibrosis.

STUDY OBJECTIVE To evaluate the effect of anticoagulant therapy on the survival of patients with idiopathic pulmonary fibrosis (IPF). DESIGN Prospective study. SETTING Five hospitals located in the Miyagi prefecture in Japan, including a university hospital, a Red Cross hospital, two public general hospitals, and a municipal hospital. PATIENTS Fifty-six patients with IPF (mean age, 69.4 years; range, 47 to 89) admitted to the hospitals from April 2001 to April 2004. INTERVENTIONS Patients were assigned to receive prednisolone alone or prednisolone plus anticoagulant therapy. The anticoagulants included oral warfarin in an outpatient setting and low-molecular-weight heparin for rehospitalized patients with severely progressive respiratory failure. MEASUREMENTS AND RESULTS There was no difference in baseline characteristics, including age, gender, clinical condition, pulmonary function, and plasma d-dimer level between the non-anticoagulant group and the anticoagulant group. The overall survival and hospitalization-free periods were assessed. There was a significant difference between survival curves of the non-anticoagulant group and the anticoagulant group, with a 2.9 hazard ratio (p = 0.04, Cox regression model). There was no significant difference in the probability of a hospitalization-free period between groups. The major cause of clinical deterioration was acute exacerbation during follow-up in the present study. Therefore, the mortality and plasma d-dimer levels in patients with an acute exacerbation were also assessed. The mortality associated with acute exacerbations of IPF in the anticoagulant group was significantly reduced compared to that in the non-anticoagulant group (18% vs 71%, respectively; p = 0.008, Fisher Exact Test). Furthermore, the plasma d-dimer levels in patients who died were significantly higher than those in survivors during acute exacerbation of IPF (3.3 +/- 2.3 microg/mL vs 0.9 +/- 0.7 microg/mL, p < 0.0001). Histologic analysis performed in three patients who died due to an exacerbation of IPF in the non-anticoagulant group demonstrated the features of usual interstitial pneumonia and acute lung injury. CONCLUSIONS Our data suggested that plasma d-dimer levels are associated with mortality in patients with an acute exacerbation of IPF, and that anticoagulant therapy has a beneficial effect on survival in patients with IPF.

[1]  D. Strollo.  Imaging of idiopathic interstitial lung diseases. Concepts and conundrums. , 2003, American journal of respiratory cell and molecular biology.

[2]  Cheng-Ming Li,et al.  Transforming Growth Factor-β1 Modifies Fibroblast Growth Factor-2 Production in Type II Cells , 2001 .

[3]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.

[4]  S. Isacson,et al.  Effect of prednisolone on the coagulation and fibrinolytic systems. , 2009, Scandinavian journal of haematology.

[5]  Paul J. Friedman,et al.  American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.

[6]  D. Rylatt,et al.  An immunoassay for human D dimer using monoclonal antibodies. , 1983, Thrombosis research.

[7]  C. Francis,et al.  INCREASED PLASMA CONCENTRATION OF CROSSLINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL INFARCTION , 1987, Thrombosis and Haemostasis.

[8]  D. Jiménez Castro,et al.  Diagnostic Value of D Dimer in Pulmonary Embolism and Pneumonia , 2001, Respiration.

[9]  G. Raghu,et al.  The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. , 1999, Chest.

[10]  J. Kruskal,et al.  Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. , 1987, The New England journal of medicine.

[11]  Y. Kawabata,et al.  Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. , 1993, Chest.

[12]  R. Trisolini,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: report of a series , 2003, European Respiratory Journal.

[13]  T. Urano,et al.  Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. , 1997, American journal of respiratory and critical care medicine.

[14]  D. Kamp.  Idiopathic pulmonary fibrosis: the inflammation hypothesis revisited. , 2003, Chest.

[15]  S. Idell.  Coagulation, fibrinolysis, and fibrin deposition in acute lung injury , 2003, Critical care medicine.

[16]  D. Slosman,et al.  Non-invasive diagnosis of venous thromboembolism in outpatients , 1999, The Lancet.

[17]  T. King,et al.  Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. , 1990, The American journal of medicine.

[18]  F. Al-Hameed,et al.  Outcome of patients admitted to the intensive care unit for acute exacerbation of idiopathic pulmonary fibrosis. , 2004, Canadian respiratory journal.

[19]  T. Urano,et al.  Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. , 1995, Thrombosis research.

[20]  M Ando,et al.  Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. , 1999, Radiology.

[21]  F. J. van der Woude,et al.  Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  G. Hunninghake,et al.  Lung inflammation and fibrosis. , 1998, American journal of respiratory and critical care medicine.

[23]  P. de Moerloose,et al.  Measurement of plasma D-dimer for diagnosis of deep venous thrombosis. , 1989, American Journal of Clinical Pathology.

[24]  B. Afessa,et al.  Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. , 2002, American journal of respiratory and critical care medicine.

[25]  W. Waldman,et al.  The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. , 2003, American journal of clinical pathology.